Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exscientia Ltd ADR (NQ: EXAI ) 5.120 -0.280 (-5.19%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Exscientia Ltd ADR < Previous 1 2 3 4 5 6 7 8 9 10 Next > AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD Today 18:49 EDT To capitalize on the transition to more AI-focused drug development investors need to understand the drug development process and the financial health and market potential of those companies under... Via Talk Markets Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout Today 7:00 EDT From Exscientia plc Via Business Wire Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... Via Talk Markets Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery July 10, 2024 From Exscientia plc Via Business Wire 3 Small-Cap Stocks With Explosive 2X Growth Potential July 08, 2024 Discover three top high-growth small-cap stocks, fueled by potential rate cuts and promising prospects in the second half of 2024. Via InvestorPlace Clinical-Stage BioTech Drug Stocks Declined 13% In June July 01, 2024 Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read Via Talk Markets EXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law Firm June 25, 2024 From The Schall Law Firm Via Business Wire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exscientia p.l.c. (EXAI) June 24, 2024 From The Law Offices of Frank R. Cruz Via Business Wire EXAI FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Exscientia p.l.c. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action – EXAI June 24, 2024 From The Rosen Law Firm PA Via GlobeNewswire EXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law Firm June 24, 2024 From The Schall Law Firm Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... Via Talk Markets EXSCIENTIA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Exscientia plc. and Encourages Investors to Contact the Firm June 21, 2024 From Bragar Eagel & Squire Via GlobeNewswire INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia June 21, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Lowey Dannenberg Notifies Exscientia p.l.c. (“Exscientia” or the “Company”) (NASDAQ: EXAI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm June 21, 2024 From Lowey Dannenberg, P.C. Via GlobeNewswire EXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law Firm June 21, 2024 From Schall Law Via GlobeNewswire EXSCIENTIA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Exscientia p.l.c. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action – EXAI June 20, 2024 From The Rosen Law Firm PA Via GlobeNewswire EXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law Firm June 18, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Equinix and Encourages Investors to Contact the Firm June 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 The global Via Talk Markets Lowey Dannenberg Notifies Exscientia p.l.c. (“Exscientia” or the “Company”) (NASDAQ: EXAI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm June 17, 2024 From Lowey Dannenberg, P.C. Via GlobeNewswire EXSCIENTIA PLC (NASDAQ: EXAI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Exscientia plc June 17, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Rosen Law Firm Urges Exscientia p.l.c. (EXAI) Stockholders with Large Losses to Contact the Firm for Information About Their Rights June 15, 2024 From The Rosen Law Firm, P.A. Via Business Wire Lowey Dannenberg Notifies Exscientia p.l.c. (“Exscientia” or the “Company”) (NASDAQ: EXAI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm June 14, 2024 From Lowey Dannenberg, P.C. Via GlobeNewswire ROSEN, A LEADING LAW FIRM, Encourages Exscientia p.l.c Investors to Secure Counsel Before Important Deadline in Securities Class Action – EXAI June 12, 2024 From The Rosen Law Firm PA Via GlobeNewswire INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia June 12, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Globe Life and Encourages Investors to Contact the Firm June 11, 2024 From Bragar Eagel & Squire Via GlobeNewswire INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to Contact the Firm June 11, 2024 From Schall Law Via GlobeNewswire EXSCIENTIA PLC (NASDAQ: EXAI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Exscientia plc June 10, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Lowey Dannenberg Notifies Exscientia p.l.c. (“Exscientia” or the “Company”) (NASDAQ: EXAI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm June 10, 2024 From Lowey Dannenberg, P.C. Via GlobeNewswire AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 The global Via Talk Markets < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.